Hepatitis C is not a 'silent disease'

Benefits of new combination therapy are not just long-term

The benefits of treating hepatitis C are not just the prevention of potential serious liver complications, but are more immediate in terms of the quality of life of patients. "Hepatitis C is not a silent disease," says Dr. John E. Ware, Jr. of Quality Metric, Inc. in Lincoln, Rhode Island. "The disease limits patients substantially in terms of what they are able to do and how they feel," says Ware. Successful treatment improves quality of life and is likely to lead to a reduced need for health care services and increased productivity at work, according to Ware.

The results of the first international study of quality of life outcomes in hepatitis C conducted by the International Hepatitis Interventional Therapy Group are reported by Ware and his colleagues in the August issue of HEPATOLOGY, the monthly peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).

"This study is the first to link the clinical success of new combination therapies for hepatitis C to how much patients are helped in their everyday lives. Those who were treated successfully according to clinical tests were also the only ones who improved in terms of their quality of life as measured by energy level, social functioning with friends and relatives, and reductions in their level of distress," Ware says.

Over 300 patients in ten countries participated in this international study, using a self-administered Hepatitis Quality of Life Questionnaire that is available from QualityMetric, Inc. (www.qmetric.com ). By translating the quality of life questionnaires into other languages, results observed in the United States and the United Kingdom for English-speaking patients could be compared with results in other countries. Comparisons revealed a similar pattern of results, although similarit

Contact: Kirk Monroe
American Association For The Study of Liver Diseases

Page: 1 2

Related biology news :

1. Risk of Hepatitis E from consumption of deer?
2. Hepatitis C infection does not alter HIV progression or treatment
3. Need, potential for Hepatitis C vaccine highlighted by Hopkins study
4. Hepatitis E recovered from rats in Los Angeles
5. Hepatitis C drug overwhelms virus with flood of mutations - surprising mechanism may improve anti-viral treatments, UCSF study finds
6. Explaining the persistence of Hepatitis C
7. High percentage of Hepatitis C patients take herbs and vitamins, according to Rush survey
8. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
9. Hepatitis E virus infection may be widespread in rats
10. Hepatitis Cs interferon resistance mechanism discovered
11. Immune Response To Hepatitis B Spares Liver Cells

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: